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Introduction
Our laboratory has previously demonstrated that adop-
tive cell transfer (ACT) of melanoma-specific memory
T cells (TM) results in a more potent local and systemic
T cell response than ACT with melanoma-specific effector
T cells (TE). However, we have also seen that TM are not
more cytotoxic than TEin vitro. We hypothesized that a
combination of TE+M ACT would have an additive effect
compared to TE and TM ACT alone.
Methods
C57BL/6 mice were inoculated with subcutaneous injec-
tions of B16F10 melanoma cells transfected to express
low levels of the lymphocytic choriomeningitis virus
(LCMV) peptide GP33 (B16GP33). GP33-specific TE,
TM, or TE+M ACT was administered seven days after
tumor inoculation. Cultured GP33-specific TE, TM, or
TE+M were stimulated with GP33 or co-cultured with
B16GP33 cells.
Results
Combinatorial TE+M ACT resulted in more potent sup-
pression of in vivo B16GP33 melanoma growth compared
to TM or TE ACT alone. TE+M ACT resulted in slightly
higher populations of total CD8+ TILs compared with
TM ACT. TE+M ACT did not result in higher numbers of
exogenously-derived transferred T cells; rather, combina-
tion ACT resulted in a profound induction of endogen-
ous TILs. In addition, combination ACT induced the
most potent systemic T cell response to tumor antigen.
In vitro, TE and TM were comparable in their ability to
inhibit of melanoma growth, but TE+M was synergistic.
This synergy was reproduced by applying conditioned
media derived from activated TM to co-culture wells con-
taining TE. The addition of neutralizing IL-2 antibody
negated this effect. TE were more effective at inhibiting
melanoma cell growth at early time points, but the
strength of this inhibition diminished over time. In con-
trast, TM became more effective at inhibiting melanoma
growth over time.
Conclusions
Overall, these data suggest that a synergistic interaction
between TE and TM may promote combinatorial ACT’s
superior anti-tumor efficacy. Combinatorial ACT’s
strong endogenous T cell infiltration and systemic
response indicates that the combination’s synergistic
effect is enhancing the host’s immune system. Our in
vitro results suggest that cytokines released by stimu-
lated TM may augment the local cytotoxicity of TE and
that the temporal differences in killing may enhance the
combination’s ability to inhibit tumor growth. Further
investigations will be performed to understand the cel-
lular and molecular mechanisms responsible for this
clinically promising observation.
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